Objectives:
In recent years, many effects of
vitamin D except on bone metabolism have been discovered. Vitamin D contributes
to the correction of the anemia by acting on the erythroid precursors in the
bone marrow via Vitamin D Receptor and provides the elimination of free
radicals and prooxidant substances secondary to iron deficiency due to its
antioxidant effect in iron deficiency anemia (IDA).
Methods: A total of 97 female premenopausal
women aged 18-44 were included in the study. Fifty patients with hemoglobin
levels below 12 mg/dl and iron deficiency were classified as IDA group, and 47
subjects with hemoglobin levels of 12 mg/dl and above were classified as
control group. The demographic data and biochemical parameters of all patients
included in the study were analyzed.
Results: The vitamin D of the patient group
was found to be 7.87 ± 3.63 ng/ml and the vitamin D of the control group was
11.84 ± 6.72 ng/ml. The difference between the groups was statistically
significant. There was a positive correlation between serum vitamin D and serum
hemoglobin, hematocrit, serum MCH, serum iron level, transferrin saturation
index, ferritin.
Conclusions: In the light of the results of our study and other studies in the
literature, we think that vitamin D deficiency may be important in patients
with IDA and that vitamin D deficiency in these individuals will contribute to
the regulation of anemia due to positive effects of vitamin D on both
erythropoiesis and hepcidin in IDA are considered. However, larger studies are
needed to clarify this issue.
Birincil Dil | İngilizce |
---|---|
Konular | Endokrinoloji, İç Hastalıkları |
Bölüm | Original Article |
Yazarlar | |
Yayımlanma Tarihi | 4 Mayıs 2020 |
Gönderilme Tarihi | 31 Ekim 2018 |
Kabul Tarihi | 16 Mart 2019 |
Yayımlandığı Sayı | Yıl 2020 Cilt: 6 Sayı: 3 |